We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$45.9B
AUM Growth
+$3.99B
Cap. Flow
+$3.07B
Cap. Flow %
6.69%
Top 10 Hldgs %
9.34%
Holding
3,639
New
509
Increased
1,872
Reduced
840
Closed
386

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$510M
2
PFE icon
Pfizer
PFE
+$265M
3
GILD icon
Gilead Sciences
GILD
+$212M
4
CMCSA icon
Comcast
CMCSA
+$191M
5
META icon
Meta Platforms (Facebook)
META
+$184M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 12.72%
3 Financials 10.51%
4 Industrials 9.69%
5 Consumer Staples 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHI icon
3376
Omega Healthcare
OHI
$13.8B
-562,360
Closed -$19.8M
OLN icon
3377
Olin
OLN
$2.17B
-750,745
Closed -$12.6M
OMC icon
3378
Omnicom Group
OMC
$23.6B
-4,800
Closed -$316K
OMER icon
3379
Omeros
OMER
$984M
-12,593
Closed -$138K
OOMA icon
3380
Ooma
OOMA
$578M
-17,600
Closed -$122K
ORCL icon
3381
Oracle
ORCL
$419B
-2,028,732
Closed -$73.3M
OVV icon
3382
Ovintiv
OVV
$17.6B
-40,300
Closed -$1.3M
PAHC icon
3383
Phibro Animal Health
PAHC
$1.38B
-89,600
Closed -$2.83M
PARA
3384
DELISTED
Paramount Global Class B
PARA
-1,753,200
Closed -$70M
PATK icon
3385
Patrick Industries
PATK
$2.81B
-118,881
Closed -$2.09M
PBR icon
3386
Petrobras
PBR
$116B
-1,299,200
Closed -$5.65M
PBR.A icon
3387
Petrobras Class A
PBR.A
$103B
-4,759,700
Closed -$17.5M
PBYI icon
3388
Puma Biotechnology
PBYI
$453M
-162,600
Closed -$12.3M
PCRX icon
3389
Pacira BioSciences
PCRX
$972M
-108,500
Closed -$4.46M
PEG icon
3390
Public Service Enterprise Group
PEG
$37.5B
-129,200
Closed -$5.45M
PH icon
3391
Parker-Hannifin
PH
$134B
-509,350
Closed -$49.6M
PIPR icon
3392
Piper Sandler
PIPR
$5.35B
-335,200
Closed -$3.03M
PSA icon
3393
Public Storage
PSA
$60.7B
-18,200
Closed -$3.85M
PTCT icon
3394
PTC Therapeutics
PTCT
$6.15B
-65,900
Closed -$1.76M
PUK icon
3395
Prudential
PUK
$34B
-140,525
Closed -$5.74M
QRVO icon
3396
Qorvo
QRVO
$8.53B
-65,906
Closed -$2.97M
QSR icon
3397
Restaurant Brands International
QSR
$25.6B
-133,087
Closed -$4.78M
RARE icon
3398
Ultragenyx Pharmaceutical
RARE
$2.66B
-3,200
Closed -$308K
RBC icon
3399
RBC Bearings
RBC
$17.5B
-131,666
Closed -$7.86M
RH icon
3400
RH
RH
$3.46B
-167,400
Closed -$15.6M

Similar funds

Jim Simons's Q4 2015 Portfolio in Review

As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.

  • Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
  • Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
  • Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
  • Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
  • Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
  • Jim Simons opened 509 new positions and closed 386 in Q4 2015.
  • Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.

Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.